Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Synthetic 12 amino acids peptide designed after subcommissural organ spondin

EU orphan designation number: EU/3/13/1206   
Active ingredient: Synthetic 12 amino acids peptide designed after subcommissural organ spondin
Indication: Treatment of spinal cord injury
Sponsor: Neuronax SAS
Biopôle Clermont Limagne, 63360 Saint Beauzire, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/119/13 (2013)8053 of 13/11/2013